{"prompt": "['Cara Therapeutics, Inc.', 'Difelikefalin (IV CR845)', 'CR845-CLIN3102', 'Clinical Study Report - Double-blind Phase', 'Cara Therapeutics Inc.', 'Confidential', 'Page 18 of 92', 'CR845-CLIN3102', '8.8.3', 'Clinical Laboratory Evaluations', '70', '8.8.4', 'Vital Signs and ECGs', '70', '8.9', 'Additional Analyses', '72', '8.9.1', 'Inflammatory Biomarkers', '72', '8.9.2', 'Missed Dialysis Visits and Incidence of Infection', '72', '8.9.3', 'ESA and IV Iron', '72', '8.9.4', 'Discontinuation Period Additional Assessments', '72', '9.0 Quality Control and Quality Assurance', '74', '9.1', 'Study Monitoring Plan', '74', '9.2', 'Audits and Inspections', '74', '9.3', 'Data Collection, Validation, and Analysis', '75', '10.0 Ethics and Regulatory Compliance', '76', '10.1', 'Independent Ethics Committee or Institutional Review Board', '76', '10.2', 'Ethical Conduct of the Study', '76', '10.3', 'Informed Consent Process', '77', '10.4', 'Patient Confidentiality', '77', '11.0 Data Handling and Quality Assurance', '79', '12.0 Administrative Procedures', '80', '12.1', 'Protocol Adherence', '80', '12.2', 'Publication of Study Findings', '80', '13.0 References', '81', '14.0 Appendix', '83', '14.1', 'Appendix 1: New York Heart Association Classification of Heart Failure', '83', '14.2', 'Appendix 2: Worst Itching Intensity Numerical Rating Scale (NRS)', '84', '14.3', 'Appendix 3: Skindex-10 Scale', '85', '14.4', 'Appendix 4: 5-D Itch Scale', '86', '14.5', 'Appendix 5: Patient Global Impression of Change', '88', '14.6', 'Appendix 6: Short Opiate Withdrawal Scale', '89', '14.7', 'Appendix 7: Objective Opiate Withdrawal Scale', '90', '15.0 Statistical Appendix', '91', '21 December 2017', 'Version 1.0', 'CONFIDENTIAL', 'Page 20 of 95']['Cara Therapeutics, Inc.', 'Difelikefalin (IV CR845)', 'CR845-CLIN3102', 'Clinical Study Report - Double-blind Phase', 'Cara Therapeutics Inc.', 'Confidential', 'Page 19 of 92', 'CR845-CLIN3102', 'LIST OF TABLES', 'Table 1.', 'Restricted and Prohibited Medications', '40', 'Table 2.', 'Schedule of Events: Double-blind Phase', '41', 'Table 3.', 'Schedule of Events: Open-label Extension Phase', '45', 'Table 4.', 'Power as a Function of Effect Size (N = 175 per arm)', '59', 'Table 5.', 'Sample Size as a Function of Odds Ratio (90% Power)', '59', 'Table 6.', 'Criteria Used to Identify Clinically Notable Vital Sign Abnormalities 71', 'LIST OF FIGURES', 'Figure 1.', 'CR845-CLIN3102 Study Schematic', '31', '21 December 2017', 'Version 1.0', 'CONFIDENTIAL', 'Page 21 of 95']['Cara Therapeutics, Inc.', 'Difelikefalin (IV CR845)', 'CR845-CLIN3102', 'Clinical Study Report - Double-blind Phase', 'Cara Therapeutics Inc.', 'Confidential', 'Page 20 of 92', 'CR845-CLIN3102', '3.0', 'List of Abbreviations', 'AESI', 'adverse event of special interest', 'ATC', 'Anatomical Therapeutic Chemical', 'CFR', 'Code of Federal Regulations', 'CI', 'confidence interval', 'CNS', 'central nervous system', 'ECG', 'electrocardiogram', 'eCRF', 'electronic case report form', 'ESA', 'erythropoiesis-stimulating agent', 'ESRD', 'end-stage renal disease', 'FDA', 'Food and Drug Administration', 'GCP', 'Good Clinical Practice', 'H', \"above the laboratory parameter's reference range\", 'ICF', 'informed consent form', 'ICH', 'International Council for Harmonisation', 'IDMC', 'Independent Data Monitoring Committee', 'IL', 'interleukin', 'IND', 'Investigational New Drug', 'IRB', 'Institutional Review Board', 'ISF', 'Investigator Site File', 'IV', 'intravenous', 'IVRS/IWRS', 'interactive voice or web response system', 'KOR', 'kappa-opioid receptor', 'L', \"below the laboratory parameter's reference range\", 'LS', 'least squares', 'MAR', 'missing at random', 'MCMC', 'Markov Chain Monte Carlo', 'MedDRA', 'Medical Dictionary for Regulatory Activities', 'MI', 'multiple imputation', 'MMRM', 'mixed effects model with repeated measures', 'MNAR', 'missing not at random', 'N', \"within the laboratory parameter's reference range\", 'NRS', 'numerical rating scale', 'OOWS', 'Objective Opiate Withdrawal Scale', 'PRO', 'patient-reported outcome', 'SAE', 'serious adverse event', 'SAP', 'statistical analysis plan', 'SE', 'standard error', 'ShOWS', 'Short Opiate Withdrawal Scale', 'SOC', 'System Organ Class', 'TEAE', 'treatment-emergent adverse event', 'ULN', 'upper limit of normal', 'Abbreviations that occur only in tables or figures are defined within the appropriate table or figure.', '21 December 2017', 'Version 1.0', 'CONFIDENTIAL', 'Page 22 of 95']\n\n###\n\n", "completion": "END"}